AJP - GI Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Gastrointest Liver Physiol 282: G617-G623, 2002. First published December 12, 2001; doi:10.1152/ajpgi.00344.2001
0193-1857/02 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/4/G617    most recent
00344.2001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (32)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ashida, K.
Right arrow Articles by Inui, K.-I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ashida, K.
Right arrow Articles by Inui, K.-I.
Vol. 282, Issue 4, G617-G623, April 2002

Thyroid hormone regulates the activity and expression of the peptide transporter PEPT1 in Caco-2 cells

Kayoko Ashida, Toshiya Katsura, Hideyuki Motohashi, Hideyuki Saito, and Ken-Ichi Inui

Department of Pharmacy, Kyoto University Hospital, Faculty of Medicine, Kyoto University, Sakyo-ku, Kyoto 606-8507, Japan

An oligopeptide transporter (PEPT1) in the small intestine plays an important role in the absorption of small peptides and peptide-like drugs. We examined the effect of thyroid hormone 3,5,3'-L-triiodothyronine (T3) on the activity and expression of PEPT1 in human intestinal Caco-2 cells. Treatment of Caco-2 cells with T3 inhibited [14C]glycylsarcosine uptake in a time- and dose-dependent manner. [14C]glycylsarcosine uptake was reduced by pretreatment of the cells with 100 nM T3 for 4 days (67% of control value), whereas methyl-alpha -D-[U-14C]glucopyranoside and [3H]threonine uptake were not decreased. Kinetic analysis showed that T3 treatment significantly decreased the maximum uptake (Vmax) value for [14C]glycylsarcosine uptake but had no effect on the Km value. Moreover, T3 treatment caused a significant decrease in the amount of PEPT1 mRNA (25% of the control). Western blotting indicated that the amount of PEPT1 protein in the apical membrane was decreased (70% of the control). These findings indicate that T3 treatment inhibits the uptake of [14C]glycylsarcosine by decreasing the transcription and/or stability of PEPT1 mRNA.

intestinal absorption; intestinal oligopeptide transporter; hormonal regulation; gene expression


This article has been cited by other articles:


Home page
 J ANIM SCIHome page
E. R. Gilbert, E. A. Wong, and K. E. Webb Jr.
BOARD-INVITED REVIEW: Peptide absorption and utilization: Implications for animal nutrition and health
J Anim Sci, September 1, 2008; 86(9): 2135 - 2155.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
H. Saito, T. Terada, J. Shimakura, T. Katsura, and K.-i. Inui
Regulatory mechanism governing the diurnal rhythm of intestinal H+/peptide cotransporter 1 (PEPT1)
Am J Physiol Gastrointest Liver Physiol, August 1, 2008; 295(2): G395 - G402.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. Shimakura, T. Terada, H. Saito, T. Katsura, and K.-i. Inui
Induction of intestinal peptide transporter 1 expression during fasting is mediated via peroxisome proliferator-activated receptor {alpha}
Am J Physiol Gastrointest Liver Physiol, November 1, 2006; 291(5): G851 - G856.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. Shimakura, T. Terada, T. Katsura, and K.-I. Inui
Characterization of the human peptide transporter PEPT1 promoter: Sp1 functions as a basal transcriptional regulator of human PEPT1
Am J Physiol Gastrointest Liver Physiol, September 1, 2005; 289(3): G471 - G477.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
Y. Shimizu, S. Masuda, K. Nishihara, L. Ji, M. Okuda, and K.-i. Inui
Increased protein level of PEPT1 intestinal H+-peptide cotransporter upregulates absorption of glycylsarcosine and ceftibuten in 5/6 nephrectomized rats
Am J Physiol Gastrointest Liver Physiol, April 1, 2005; 288(4): G664 - G670.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. A. Adibi
Regulation of expression of the intestinal oligopeptide transporter (Pept-1) in health and disease
Am J Physiol Gastrointest Liver Physiol, November 1, 2003; 285(5): G779 - G788.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
H. Daniel and I. Rubio-Aliaga
An update on renal peptide transporters
Am J Physiol Renal Physiol, May 1, 2003; 284(5): F885 - F892.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online